"Reactive Airway Disease" is Not a Valid Medical Diagnosis—Use "Asthma" Instead
The term "reactive airway disease" (RAD) should be abandoned in clinical practice, as it delays appropriate asthma diagnosis and treatment without providing any clinical benefit. 1 The EPR-3 guidelines explicitly state that clinicians should avoid using labels like "reactive airway disease" because they lead to underdiagnosis of asthma and missed opportunities for appropriate anti-inflammatory treatment, particularly in young children.
Key Differences in Clinical Practice
Reactive Airway Disease (RAD)
- Not a recognized diagnosis in major asthma guidelines 1
- A vague descriptive term that merely indicates bronchospasm occurred
- Often used inappropriately to avoid committing to an asthma diagnosis, especially in young children
- Delays preventive care: Children diagnosed with RAD receive controller medications and action plans an average of 9 months later than those diagnosed with asthma 2
- No specific treatment pathway or management guidelines exist
Asthma
- Well-defined chronic inflammatory disorder of the airways involving mast cells, eosinophils, T lymphocytes, and other inflammatory cells 1
- Characterized by:
- Variable and reversible airflow obstruction
- Bronchial hyperresponsiveness
- Underlying chronic inflammation
- Recurrent symptoms (wheeze, cough, breathlessness, chest tightness)
- Has established diagnostic criteria and evidence-based treatment algorithms 1
- Requires long-term anti-inflammatory therapy (inhaled corticosteroids) for persistent symptoms
Important Clinical Caveat: RADS Exception
The only legitimate use of "reactive airways" terminology is for Reactive Airways Dysfunction Syndrome (RADS), which is a distinct entity from asthma 3, 4:
- Develops after single, acute, high-level exposure to irritant gases, vapors, or fumes (e.g., chlorine, ammonia)
- Symptoms begin within minutes to hours (not days or weeks) after exposure
- Requires documented normal pre-exposure pulmonary function
- Results in persistent asthma-like symptoms and bronchial hyperreactivity
- Pathologically distinct: predominantly lymphocytic inflammation (not eosinophilic) with less reversibility than typical asthma 5, 6
- Most commonly caused by chlorine or chlorine-releasing agents 4
Why This Distinction Matters for Patient Outcomes
Research demonstrates that using "RAD" instead of "asthma" has real consequences 2:
- Delayed controller medication: Children with RAD diagnoses wait significantly longer to receive inhaled corticosteroids
- Delayed asthma action plans: Preventive care measures are postponed until a subsequent "asthma" diagnosis is made
- No difference in 2-year outcomes: Despite the delayed care, clinical outcomes eventually converge, suggesting the initial RAD diagnosis was simply incorrect asthma labeling
The British Thoracic Society guidelines emphasize that asthma is diagnosed clinically based on variable symptoms (wheeze, breathlessness, chest tightness, cough) that are intermittent, worse at night, and triggered by specific exposures 7, 8. When these features are present with documented airflow variability or reversibility, the diagnosis is asthma—not "reactive airway disease."
Practical Approach
For children ages 0-4 years with recurrent wheezing:
- Diagnosis is challenging due to difficulty obtaining objective measurements 1
- However, chronic airway inflammation and structural changes can develop in preschool years
- Make the asthma diagnosis when clinical features suggest it, rather than using placeholder terms like RAD
- Initiate appropriate controller therapy to reduce morbidity
For any patient with recurrent respiratory symptoms:
- Document pattern of symptoms (variable, intermittent, nocturnal, triggered)
- Obtain objective evidence when possible (spirometry, peak flow variability, bronchodilator response)
- If consistent with asthma, diagnose as asthma and initiate guideline-based treatment
- Reserve "reactive airways" terminology exclusively for true RADS cases with documented acute high-level irritant exposure